SVCC
Strong SellSinkerStellar V Capital Corp. · Financial Services · United States · $230M · Avg Vol: $155K/d
Sinker: Weak, expensive and falling. Nothing here to keep it afloat.
ABOUT STELLAR V CAPITAL CORP.
Read
Stellar V Capital Corp. is a special purpose acquisition company (SPAC) established to pursue a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. As a shell company with no ongoing operations, its value is derived from the experience of its management team in identifying and completing a compelling acquisition target. The success of SVCC hinges on its ability to find an attractive private company to bring public.
FINANCIAL SUMMARY (USD)
| Year | 2024 | 2025 | TTM |
|---|---|---|---|
| Revenue | 0 | 0 | — |
| EPS | -0.01 | 0.26 | 0.22 |
| Shares | 21.6M | 21.6M | — |
| Debt | 0.2M | — | 50.0K |
| Equity | -50.8K | 151.8M | — |
| Op CF | 0 | -0.6M | -0.5M |
| Inv CF | 0 | -151.1M | — |
| Fin CF | 0 | 152.0M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Financial Services, ranked by industry match, size, and score similarity. Cross-listings of SVCC are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| SVCC | Stellar V Capital Corp.(you) | $230M | 19 | Strong Sell |
| MACI | Melar Acquisition Corp. I | $238M | 19 | Strong Sell |
| ONCH | 1RT Acquisition Corp. | $223M | 19 | Strong Sell |
| CCAQ | Collective Acquisition Corp. | $212M | 19 | Strong Sell |
| TDAC | Translational Development Acquisition Corp. | $209M | 19 | Strong Sell |
| OACC | Oaktree Acquisition Corp. III Life Sciences | $264M | 18 | Strong Sell |
| VNME | Vendome Acquisition Corporation I | $257M | 22 | Sell |
| DYOR | Insight Digital Partners II | $233M | 24 | Sell |
| MCGA | Yorkville Acquisition Corp. | $244M | 15 | Strong Sell |
| DMAA | Drugs Made In America Acquisition Corp. | $261M | 16 | Strong Sell |
Peer medians: ROE 9.6% · P/E 12.6x · Gross margin 100.0%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.